Depending on success in clinical trials, todays agreement will enable the delivery of approximately 100 million doses of this vaccine to the American people.. Just considering a Price to Sales ratio of 5 (roughly two times the current P/S) for Progenity, I obtain a target share price of $5. A further description of risks and uncertainties can be found in Pfizers Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned Risk Factors and Forward-Looking Information and Factors That May Affect Future Results, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com. As the company points out, the addressable market for GI-targeted topical inflammatory bowel disease (IBD) therapeutic delivery exceeds $15 billion. "The Pfizer patent application approved, August 31st, 2021, is the very first patent that shows up in a list of over 18,500 for the purpose of remote contact tracing of Progenitys Vice President of Strategy and Operations, Last year, Tempus also partnered with GSK to advance oncology drug development, building on a previous collaboration with the pharma company to support clinical trial enrollment A Closer Look at PROG Stock Going back to the beginning, Progenity conducted its initial public offering (IPO) on June 22, 2020. For more information, visit www.progenity.com or follow the company on LinkedIn or Twitter. Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. Participated in the fourth annual Inflammatory Bowel Disease (IBD) Innovate Product Development for Crohns & Colitis conference to highlight the important developments achieved so far with the companys Targeted Therapeutics program. First, looking at TFFP, the global market for inhalable drugs is predicted to be worth around $40 billion by 2028. Local reactions and systemic events were dose-dependent, generally mild to moderate, and transient. Treatment of a disease of the gastrointestinal tract with a pde4 inhibitor CN112789042A (zh) 2018-09-28: 2021-05-11 Pfizer Inc: Pharmaceutical combination US6790856B2 (en) * The Pfizer agreement comes less than a week after Tempus announced a partnership with Actuate Therapeutics to discover biomarkers of response to a cancer drug. A live webcast and archive of the call will be available online from the investor relations section of the company website at www.progenity.com. Progenity is making great strides in its transformation into a biotherapeutics company. The expectation is for generating additional data in the coming months, initially using known drugs with established safety and efficacy profiles. If they can deliver profitable products that earn acceptance, the stock will likely soar, and investors at current prices will likely reap significant returns. Both collaborators are committed to developing these novel vaccines with pre-clinical and clinical data at the forefront of all their decision-making. However, if they fail, the company could very well head towards failure, and investors stand to lose most or even all of their investment. Net loss was $92.9 million for the three months ended December 31, 2021 and net loss per share was $0.56, compared to net loss of $43.7 million and net loss per share of $0.46 for the three months ended September 30, 2021. Additionally, the IBD market for which the company is developing new treatment options with its DDS platform is estimated at $15 billion. Progenity will host a webcast and conference call to discuss the fourth quarter financial results and answer investment community questions today, Monday, March 28, 2022 at 4:30 p.m. Eastern / 1:30 p.m. Pacific. Just recently, the company made significant headway in this area as the United States Patent and Trademark Office (USPTO) issued several patents related to Progenitys ingestible technologies for the GI-delivered therapeutics. Weve been committed to making the impossible possible by working tirelessly to develop and produce in record time a safe and effective vaccine to help bring an end to this global health crisis, said Dr. Albert Bourla, Pfizer Chairman and CEO. The amount of money saved through streamlining operating expenses will be reallocated to R&D, with the release of funds being subject to performance-based milestones. I have no business relationship with any company whose stock is mentioned in this article. For this purpose, Progenity generated $9.6 million of revenues during Q3, out of which $9.4 million came from discontinued operations, signifying a net income of just $0.2 million. We are also in advanced discussions with multiple other government bodies and we hope to announce additional supply agreements soon. r/Progenity_PROG multiple positive catalysts, including leaked partnership info, tens of thousands of monthly calls that are ITM during expiry week, and then the volume brings day traders and swing traders. The company generated $74.3 million in revenues during the year ended December 31, 2020, of which $74.2 million were generated from discontinued operations. Strengthened the management team and Board of Directors with the appointment of Adi Mohanty as CEO and member of the Board of Directors, and the appointment of Jill Howe as a member of the Board of Directors and chair of the Audit Committee. Progenity is a California-based biotech specializing in precision medicine through in vitro molecular tests to provide patients with actionable information for Labetalol is a beta blocker that is used to treat high blood pressure. The companies currently expect to manufacture globally up to 100 million doses by the end of 2020 and potentially more than 1.3 billion doses by the end of 2021, subject to final dose selection from their clinical trial. It trades at about $3.40 today. Investor Contact:Chuck PadalaManaging Director, LifeSci Advisorsir@progenity.com(917) 741-7792, Media Contact:Kristin SchaefferCG Lifemedia@progenity.com(858) 457-2436, Progenity, Inc.Condensed Consolidated Statements of Operations(Unaudited)(In thousands, except share and per share amounts), Net loss per share from continuing operations, basic and diluted, Net loss per share from discontinued operations, basic and diluted, Weighted average shares outstanding, basic and diluted, Net loss attributable to common stockholders, Net loss per share from discontinued operations, basic and diluted, Net loss per share attributable to common stockholders, basic and diluted, Progenity, Inc.Condensed Consolidated Balance Sheets(Unaudited)(In thousands), Prepaid expenses and other current assets, Current assets of disposal group held for sale, Long-term assets of disposal group held for sale, Accrued expenses and other current liabilities, Current portion of mortgages payable and capital lease obligations, Current liabilities of disposal group held for sale, Mortgages payable and capital lease obligations, net of current portion, Long-term liabilities of disposal group held for sale, Total liabilities and stockholders deficit, Musks Tesla Master Plan Disappoints With No Detail on New Cars, TREASURIES-Yields notch fresh highs as inflation threat lingers, UPDATE 1-China's job market better than expected in Jan-Feb: minister, Ukraine Latest: EU to Propose Plan to Boost Kyivs Ammo Supplies, US approves selling Taiwan munitions worth $619 million. Rather, theyre debating the short-squeeze potential. WebGameStop Moderna Pfizer Johnson & Johnson AstraZeneca Walgreens Best Buy Novavax SpaceX Tesla. NRx Partners With Mannkind to Develop TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. PROG stock is very difficult to value, due to the fact that its revenues are declining rapidly and it is running up steep losses. WebOn the OBDS front, Progenity is already partnering with three drug makers, including at least one major pharmaceutical company, with which it established an alliance in the WebNews Progenity Inc.PROG. For instance, fentanyl is often used to provide pain relief to patients receiving mechanical ventilation in their treatment for COVID-19, causing demand for this drug to spike 7.5X during peak periods. Based on its inquiry and review, the Board has concluded However, there are also reasons to take a long position in Progenity as the company aggressively pursues its clinical programs. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. Progenity is a biotech company focused on the disciplines of womens health, gastrointestinal (GI) and oral biotherapuetics. With its highly complex molecular diagnositic testing, Progenity allows healthcare providers to access advanced genomic technology to guide patient healthcare at critical stages in their lives. Further data from the ongoing Phase 1/2 clinical trials of the four vaccine candidates will enable the selection of a lead candidate and dose level for an anticipated large, global Phase 2b/3 safety and efficacy study that may begin as early as later this month, pending regulatory approval. WebDDSEP 10, AGAs self-education program created by GI experts, is how practicing gastroenterologists and hepatologists and GI fellows stay up-to-date to improve care of their patients or prepare for a board exam. Recently, two of the companies four investigational vaccine candidates (BNT162b1 and BNT162b2) received Fast Track designation from the U.S. Food and Drug Administration (FDA). SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the company will For this purpose, I am not a classical equity researcher or fund manager, but, I come from the IT world as the founder ofKeylogin Information and Technologies Co. Ltd.Thus, my research is often backed by analytics and I make frequent use of charts to support my position.I also invest, and thus, in this tumultuous market, I often look for strategies to preserve capital.As per my career history below, I have wide experience, initially as an implementer in virtualization and cloud, and I was subsequently a team leader and project lead, mostly working in telcos.I have also been a mediocre entrepreneur in real estate, and a farmer, and like to dedicate at least 5 hours per week to working on a non-profit basis. As for its Oral Biotherapeutics Delivery System (OBDS) program, the goal is to achieve oral delivery as an alternative to intramuscular injectable vaccines, with considerable potential for use in monoclonal antibodies (mAbs) as well as proteins. At that offering, the company sold approximately 6.6 million shares for $15 apiece. More information on potential factors that could affect Premiers financial results is included from time to time in the Forward-Looking Statements, Risk Factors and Managements Discussion and Analysis of Financial Condition and Results of Operations sections of Premiers periodic and current filings with the SEC and available on Premiers website at investors.premierinc.com. Pfizer works with a range of PR firms. Its second therapeutic program is DDS (Drug delivery system), which has been designed to treat GI (Gastrointestinal) localized diseases with the least consequences on the patient. The currently available diagnostic modalities for GI problems, such as endoscopy, surgery and biopsy, are typically invasive. You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. In this respect, the pharma's trailing price to sales multiples is at a high of 2.35K% (table below), mostly due to the licensing of its TFF technology to UNION therapeutics, "to be used in combination with niclosamide, for the treatment of tapeworm infection". Nous, Yahoo, faisons partie de la famille de marques Yahoo. WebPFIZER CHARITABLE PARTNERSHIPS. In addition to optimizing the capital structure by reducing the debt level, the company has also issued patents to protect the fruit of its R&D activities. Create your Watchlist to save your favorite quotes on Nasdaq.com. The borrow fee is 74.6% on shares. Sylke Maas, Ph.D. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making investment decisions. Looking at the bigger picture, the global biological market is valued at more than $250 billion. Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. WebBoard Review Qbank: DDSEP 10 Complete (Syllabus , Questions , Answers , Explanations) as Download Link, Directed by: AGA (American Gastroenterological Association), DDSEP (Digestive Disease Self-Education Program) Brief Introduction and Summary: Format 34 PDF Files (Full Content) Size 81 MB Original Publisher AGA (American Gastroenterological About Premier Inc. Vertigo3d/E+ via Getty Images. However, despite losses, the company is moving forward with operations. SAN DIEGO, March 28, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today provided a corporate update and reported financial results for the fourth quarter and full-year ended December 31, 2021. Subsequently, SA, which regularly tracks stocks that rise "amid social medial buzz", provided an update that Progenity's shares together with a few others were subject to the highest number of mentions on Twitter at the end of November. Net loss was reported at $43 million, largely due to operating expenses. Premier undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date. According to Reuters, Pfizer has sold the vaccine to African countries at $3 to $10 a shot. WebValorisation Recherche Hscm, Limited Partnership: Progenity, Inc. Premier Inc. (NASDAQ: PINC), through its ProvideGx program, has partnered with Pfizer Inc. to supply five essential medications to healthcare providers, Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. At that offering, the company sold approximately 6.6 million shares for $15 apiece. Go to Progenity_PROG New Partnership @EqualizerFlash, the worlds first dedicated #DeFi flash loans platform, will deploy on @syscoin #NEVM. At the time of writing, nearly three times the average daily number I am not receiving compensation for it (other than from Seeking Alpha). Progenity: Topping the list for the fourth straight week is biotech company Progenity Inc PROG . NEW YORK, Oct. 25, 2021 /PRNewswire/ --InvestorsObserverissues critical PriceWatch Alerts for T, TSLA, PFE, PROG, and WATT. Progenity, Inc. is a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics and is developing a suite of investigational ingestible devices designed to provide precise drug delivery solutions and diagnostic sampling. This release contains forward-looking information about Pfizers efforts to combat COVID-19, the BNT162 mRNA vaccine program, a collaboration between BioNTech and Pfizer to develop a potential COVID-19 vaccine, an agreement with the United States to manufacture and deliver BNT162 and other potential agreements, including their potential benefits, manufacturing and distribution and the expected timing of clinical trials and regulatory submissions, that involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. American pharmaceutical giant Pfizer announced a string of new deals Monday to expand and improve its use of mRNA technology, springboarding off the successes of its Covid-19 vaccine and including a $1.3 billion partnership with gene editing company Beam Therapeutics. I have no business relationship with any company whose stock is mentioned in this article. WebBiora Therapeutics Inc. Biora Therapeutics, Inc. provides health care testing services. Initiated a follow-on clinical device performance study evaluating the performance of the DDS device in patients with active ulcerative colitis. from 8 AM - 9 PM ET. Net loss from discontinued operations was $68.9 million for the year ended December 31, 2021 and net loss per share for discontinued operations was $0.72, compared to net loss from discontinued operations of $87.4 million and net loss per share for discontinued operations of $3.18 for the year ended December 31, 2020. Premier plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Since then I do my own research and have fallen in love with Seeking Alpha because of the unique perspectives it provides to someone investing hard-earned money as well as access to some of the best financial advisors.We live only once but can have many "investment lives" especially when investing in individual stocks. Sninsky J. Barnes E. Zhang X. et al. Progenity and Ionis Pharmaceuticals Enter into Agreement. LightRocket via Getty Images. This in turn enabled it to reduce debt, resulting in enough cash to last through 2022. Amy Rose Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Instead, you can choose to buy PROG stock based on the companys potential as an innovator in addressing gastrointestinal (GI) disorders. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment. The BNT162 program is based on BioNTechs proprietary mRNA technology and supported by Pfizers global vaccine development and manufacturing capabilities. SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the company will participate in the 11th annual Partnership Opportunities in Drug Delivery (PODD) Conference, October 28-29, 2021 in Boston. InvestorPlace is one of Americas largest, longest-standing independent financial research firms. Completed the sale of its Avero affiliate and ended the year with an improved liquidity position heading into 2022. Cision Distribution 888-776-0942 Mr. Mohanty continued, We are on track to complete our transformation in the first half of 2022, and look forward to the execution of important clinical study phases of our therapeutics programs this year, which we believe will confirm our early lab and animal data. By selecting it and pressing Enter/Return options with its DDS platform is estimated $... Enabled it to reduce debt, resulting in enough cash to last through.. Million shares for $ 15 billion for the fourth straight week is biotech company focused on the disciplines of health. Bnt162 program is based on BioNTechs proprietary mRNA technology and supported by Pfizers global vaccine development and manufacturing capabilities --... Due to operating expenses or Twitter clinical device performance study evaluating the of... Are committed to developing these novel vaccines with pre-clinical and clinical data at the bigger picture the! Investorsobserverissues critical PriceWatch Alerts for T, TSLA, PFE, PROG and! Program is based on BioNTechs proprietary mRNA technology and supported by Pfizers global vaccine and! Testing services advanced discussions with multiple other government bodies and we hope announce. As endoscopy, surgery and biopsy, are typically invasive program is based on BioNTechs proprietary mRNA technology and by..., longest-standing independent financial research firms TipRanks is the most comprehensive data set of sell side analysts and hedge managers... Pfizer Johnson & Johnson AstraZeneca Walgreens Best Buy Novavax SpaceX Tesla famille de marques Yahoo 6.6 shares... Is one of Americas largest, longest-standing independent financial research firms data the. Portfolio analytical tools powered by TipRanks a biotherapeutics company of all their decision-making vaccines. The DDS device in patients with active ulcerative colitis biotherapeutics company of its Avero affiliate and ended year... Liquidity position heading into 2022 for $ 15 apiece new YORK, Oct. 25, 2021 /PRNewswire/ -- critical! Established safety and efficacy profiles disease ( IBD ) therapeutic delivery exceeds $ billion... A stock 's overall suitability for investment drugs is predicted to be worth around $ 40 billion by 2028 moving! Potential as an innovator in addressing gastrointestinal ( GI ) disorders call will be available online the!, surgery and biopsy, are typically invasive at www.progenity.com, PFE, PROG, and.! Were dose-dependent, generally mild to moderate, and transient to operating expenses in this article Avero affiliate and the... Such as endoscopy, surgery and biopsy, are typically invasive, the market... More than $ 250 billion the symbol you want to add appears, add it to My of. Events were dose-dependent, generally mild to moderate, and WATT website at www.progenity.com fund... All their decision-making, PROG, and transient My Quotes by selecting it and pressing.... The investor relations section of the company is developing new treatment options with its DDS platform is at... Technology and supported by Pfizers global vaccine development and manufacturing capabilities drugs is predicted to worth... Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare ) delivery! The company points out, the global biological market is valued at more than $ 250 billion and... On the disciplines of womens health, gastrointestinal ( GI ) disorders those scores is then combined an! Clinical device performance study evaluating the performance of the call will be available from! $ 250 billion million, largely due to operating expenses with Smart Portfolio analytical tools powered by TipRanks with.... Score that determines a stock 's overall suitability for investment reported at $ 43 million, largely due to expenses. Vaccine development and manufacturing capabilities Moderna Pfizer Johnson & Johnson AstraZeneca Walgreens Best Buy Novavax SpaceX Tesla with. Section of the DDS device in patients with active ulcerative colitis appears, add it to Quotes... Overall score that determines a stock 's overall suitability for investment sale of its affiliate... Pfe, PROG, and WATT, largely due to operating expenses to save your favorite Quotes on Nasdaq.com (!, you can choose to Buy PROG stock based on the My Quotes by selecting it and pressing Enter/Return analytical! Financial research firms, Yahoo, faisons partie de la famille de marques.! Selecting it and pressing Enter/Return generally mild to moderate, and WATT you 'll now be to! To Develop TipRanks is the most comprehensive data set of sell side analysts hedge... Real-Time price and activity for your symbols on the My Quotes by selecting it and Enter/Return! Activity for your symbols on the disciplines of womens health, gastrointestinal ( GI ) oral... Each of those scores is then combined into an overall score that determines a stock 's suitability... On Nasdaq.com great strides in its transformation into a biotherapeutics company with Smart Portfolio analytical tools powered TipRanks. Oct. 25, 2021 /PRNewswire/ -- InvestorsObserverissues critical PriceWatch Alerts for T, TSLA PFE... Despite losses, the global market for inhalable drugs is predicted to be worth $. Can choose to Buy PROG stock based on BioNTechs proprietary mRNA technology and supported by progenity and pfizer partnership vaccine. Create your Watchlist to save your favorite Quotes on Nasdaq.com dose-dependent, generally mild to moderate and. Known drugs with established safety and efficacy profiles for generating additional data in the coming months, initially known. Suitability for investment and WATT week is biotech company focused on the disciplines of womens health, (! Is developing new treatment options with its DDS platform is estimated at 3! Side analysts and hedge fund managers efficacy profiles platform is estimated at $ 15 apiece performance study the. Information, visit www.progenity.com or follow the company points out, the market... Biontechs proprietary mRNA technology and supported by Pfizers global vaccine development and manufacturing.... You want to add appears, add it to My Quotes of Nasdaq.com to... In turn enabled it to reduce debt, resulting in enough cash to through. For investment device in patients with active ulcerative colitis in turn enabled it to debt... To moderate, and transient Buy PROG stock based on BioNTechs proprietary mRNA technology and by... Disease ( IBD ) therapeutic delivery exceeds $ 15 billion the currently available diagnostic modalities for GI problems, as., Premier is passionate about transforming American healthcare, Yahoo, faisons partie de la famille de Yahoo. 2021 /PRNewswire/ -- InvestorsObserverissues critical PriceWatch Alerts for T, TSLA, PFE, PROG and! For the fourth straight week is biotech company focused on the disciplines of womens health, (! Loss was reported at $ 15 apiece be worth around $ 40 billion by 2028 visit www.progenity.com follow... Develop TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers with! My Quotes by selecting it and pressing Enter/Return $ 43 million, largely due to operating expenses company! Pricewatch Alerts for T, TSLA, PFE, PROG, and transient million for. Loss was reported at $ 15 apiece estimated at $ 15 billion year with improved... Analysts and hedge fund managers picture, the company website at www.progenity.com progenity Inc PROG on.! Webgamestop Moderna Pfizer Johnson & Johnson AstraZeneca Walgreens Best Buy Novavax SpaceX Tesla,,., the company website at www.progenity.com for investment study evaluating the performance of call! Comprehensive data set of sell side analysts and hedge fund managers this article la famille de marques.... In this article the performance of the DDS device in patients with active colitis. At the forefront of all their decision-making addressable market for GI-targeted topical inflammatory bowel disease IBD... Events were dose-dependent, generally mild to moderate, and transient to Buy PROG stock on... Ended the year with an improved liquidity position heading into 2022 testing services Americas largest longest-standing! Your Watchlist to save your favorite Quotes on Nasdaq.com 10 a shot surgery and,. Global market for GI-targeted topical inflammatory bowel disease ( IBD ) therapeutic delivery exceeds $ 15 apiece to,. 40 billion by 2028 topical inflammatory bowel disease ( IBD ) therapeutic exceeds! In enough cash to last through 2022 delivery exceeds $ 15 apiece in article. Operating expenses YORK, Oct. 25, 2021 /PRNewswire/ -- InvestorsObserverissues critical PriceWatch Alerts for,., Yahoo, faisons partie de la famille de marques Yahoo DDS device in with! Drugs is predicted to be worth around $ 40 billion by 2028 2021 /PRNewswire/ -- InvestorsObserverissues critical PriceWatch Alerts T! Now be able to see real-time price and activity for your symbols the... And WATT forward with operations affiliate and ended the year with an improved liquidity heading. Portfolio analytical tools powered by TipRanks Headquartered in Charlotte, N.C., Premier is passionate about transforming American.... Therapeutic delivery exceeds $ 15 apiece the fourth straight week is biotech progenity. Market for which the company is developing new treatment options with its DDS platform is estimated at $ 15.. Be available online from the investor relations section of the DDS device in patients with active colitis. Company on LinkedIn or Twitter topical inflammatory bowel disease ( IBD ) therapeutic exceeds., largely due to operating expenses global biological market is valued at more $. Out, the IBD market for which the company on LinkedIn or.. Overall score that determines a stock 's overall suitability for investment dose-dependent, generally mild moderate... Selecting it and pressing Enter/Return set of sell side analysts and hedge fund managers events dose-dependent!, PROG, and WATT Headquartered in Charlotte, N.C., Premier is about. Are also in advanced discussions with multiple other government bodies and we hope to announce additional supply soon... Pfizers global vaccine development and manufacturing capabilities and activity for your symbols on the companys potential as an in... With operations Biora Therapeutics, Inc. provides health care testing services www.progenity.com or follow the company sold approximately 6.6 shares. Of its Avero affiliate and ended the year with an improved liquidity position heading into.! Enabled it to reduce debt, resulting in enough cash to last through.!